CBRE Group, Inc. Announces Increase in Stock Repurchase Authorization

CBRE Group, Inc. (NYSE: CBRE) recently disclosed in a filing with the Securities and Exchange Commission that its Board of Directors had sanctioned an extension to the company’s existing stock repurchase authorization. The announcement, released on November 21, 2024, highlighted the approval of an additional $5.0 billion for stock repurchases. This new authorization supplements the […]

Leave a Reply

Your email address will not be published.

Previous post Fura Gems (CVE:FURA) Stock Price Down 3.3% – Time to Sell?
Next post Hillstream BioPharma Terminates Agreement with Intract Pharma Ltd, Appoints New Board MemberWASHINGTON, D.C. — On November 20, 2024, Tharimmune, Inc., with its principal executive offices located in Bridgewater, New Jersey, filed a Form 8-K with the